Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation
Condition(s):Immunological Pure Red Cell AplasiaLast Updated:September 29, 2022Not yet recruiting